Financing Receivables (Tables)
|
3 Months Ended |
Mar. 31, 2018 |
| Financing Receivables |
|
| Summary of the components of financing receivables |
|
|
|
Investment in
|
|
|
|
Client Loan and
|
|
|
|
|
|
|
Sales-Type and
|
|
Commercial
|
|
Installment Payment
|
|
|
|
|
(Dollars in millions)
|
|
Direct Financing
|
|
Financing
|
|
Receivables/
|
|
|
|
|
At March 31, 2018
|
|
Leases
|
|
Receivables
|
|
(Loans)
|
|
Total
|
|
|
Financing receivables, gross
|
|
$
|
7,130
|
|
$
|
10,120
|
|
$
|
12,746
|
|
$
|
29,996
|
|
|
Unearned income
|
|
(537
|
)
|
(36
|
)
|
(628
|
)
|
(1,201
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
Recorded Investment
|
|
$
|
6,594
|
|
$
|
10,084
|
|
$
|
12,118
|
|
$
|
28,795
|
|
|
Allowance for credit losses
|
|
(112
|
)
|
(19
|
)
|
(210
|
)
|
(341
|
)
|
|
Unguaranteed residual value
|
|
558
|
|
—
|
|
—
|
|
558
|
|
|
Guaranteed residual value
|
|
89
|
|
—
|
|
—
|
|
89
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total financing receivables, net
|
|
$
|
7,128
|
|
$
|
10,065
|
|
$
|
11,908
|
|
$
|
29,101
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Current portion
|
|
$
|
3,102
|
|
$
|
10,065
|
|
$
|
7,078
|
|
$
|
20,245
|
|
|
Noncurrent portion
|
|
$
|
4,026
|
|
$
|
—
|
|
$
|
4,830
|
|
$
|
8,856
|
|
|
|
|
Investment in
|
|
|
|
Client Loan and
|
|
|
|
|
|
|
Sales-Type and
|
|
Commercial
|
|
Installment Payment
|
|
|
|
|
(Dollars in millions)
|
|
Direct Financing
|
|
Financing
|
|
Receivables/
|
|
|
|
|
At December 31, 2017
|
|
Leases
|
|
Receivables
|
|
(Loans)
|
|
Total
|
|
|
Financing receivables, gross
|
|
$
|
7,128
|
|
$
|
11,649
|
|
$
|
13,311
|
|
$
|
32,087
|
|
|
Unearned income
|
|
(535
|
)
|
(32
|
)
|
(644
|
)
|
(1,210
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
Recorded Investment
|
|
$
|
6,593
|
|
$
|
11,617
|
|
$
|
12,667
|
|
$
|
30,877
|
|
|
Allowance for credit losses
|
|
(103
|
)
|
(21
|
)
|
(211
|
)
|
(336
|
)
|
|
Unguaranteed residual value
|
|
630
|
|
—
|
|
—
|
|
630
|
|
|
Guaranteed residual value
|
|
100
|
|
—
|
|
—
|
|
100
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total financing receivables, net
|
|
$
|
7,220
|
|
$
|
11,596
|
|
$
|
12,456
|
|
$
|
31,272
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Current portion
|
|
$
|
2,900
|
|
$
|
11,596
|
|
$
|
7,226
|
|
$
|
21,721
|
|
|
Noncurrent portion
|
|
$
|
4,320
|
|
$
|
—
|
|
$
|
5,230
|
|
$
|
9,550
|
|
|
| Schedule of financing receivables and allowance for credit losses by portfolio segment |
|
(Dollars in millions)
|
|
|
|
|
|
|
|
|
|
|
At March 31, 2018
|
|
Americas
|
|
EMEA
|
|
Asia Pacific
|
|
Total
|
|
|
Recorded Investment
|
|
|
|
|
|
|
|
|
|
|
Lease receivables
|
|
$
|
3,898
|
|
$
|
1,337
|
|
$
|
1,359
|
|
$
|
6,594
|
|
|
Loan receivables
|
|
6,272
|
|
3,493
|
|
2,353
|
|
12,118
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Ending balance
|
|
$
|
10,170
|
|
$
|
4,829
|
|
$
|
3,712
|
|
$
|
18,711
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Recorded investment collectively evaluated for impairment
|
|
$
|
10,038
|
|
$
|
4,775
|
|
$
|
3,632
|
|
$
|
18,446
|
|
|
Recorded investment individually evaluated for impairment
|
|
$
|
132
|
|
$
|
54
|
|
$
|
80
|
|
$
|
265
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Allowance for credit losses
|
|
|
|
|
|
|
|
|
|
|
Beginning balance at January 1, 2018
|
|
|
|
|
|
|
|
|
|
|
Lease receivables
|
|
$
|
63
|
|
$
|
9
|
|
$
|
31
|
|
$
|
103
|
|
|
Loan receivables
|
|
108
|
|
52
|
|
51
|
|
211
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
$
|
172
|
|
$
|
61
|
|
$
|
82
|
|
$
|
314
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Write-offs
|
|
$
|
(1
|
)
|
$
|
(1
|
)
|
$
|
0
|
|
$
|
(2
|
)
|
|
Recoveries
|
|
0
|
|
—
|
|
—
|
|
0
|
|
|
Provision
|
|
9
|
|
(5
|
)
|
1
|
|
5
|
|
|
Other
|
|
1
|
|
2
|
|
2
|
|
4
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Ending balance at March 31, 2018
|
|
$
|
180
|
|
$
|
57
|
|
$
|
85
|
|
$
|
322
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Lease receivables
|
|
$
|
71
|
|
$
|
8
|
|
$
|
33
|
|
$
|
112
|
|
|
Loan receivables
|
|
$
|
109
|
|
$
|
49
|
|
$
|
52
|
|
$
|
210
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Related allowance, collectively evaluated for impairment
|
|
$
|
50
|
|
$
|
14
|
|
$
|
7
|
|
$
|
71
|
|
|
Related allowance, individually evaluated for impairment
|
|
$
|
131
|
|
$
|
43
|
|
$
|
78
|
|
$
|
251
|
|
|
(Dollars in millions)
|
|
|
|
|
|
|
|
|
|
|
At December 31, 2017:
|
|
Americas
|
|
EMEA
|
|
Asia Pacific
|
|
Total
|
|
|
Recorded Investment
|
|
|
|
|
|
|
|
|
|
|
Lease receivables
|
|
$
|
3,911
|
|
$
|
1,349
|
|
$
|
1,333
|
|
$
|
6,593
|
|
|
Loan receivables
|
|
6,715
|
|
3,597
|
|
2,354
|
|
12,667
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Ending balance
|
|
$
|
10,626
|
|
$
|
4,946
|
|
$
|
3,687
|
|
$
|
19,259
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Recorded investment collectively evaluated for impairment
|
|
$
|
10,497
|
|
$
|
4,889
|
|
$
|
3,604
|
|
$
|
18,990
|
|
|
Recorded investment individually evaluated for impairment
|
|
$
|
129
|
|
$
|
57
|
|
$
|
83
|
|
$
|
269
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Allowance for credit losses
|
|
|
|
|
|
|
|
|
|
|
Beginning balance at January 1, 2017
|
|
|
|
|
|
|
|
|
|
|
Lease receivables
|
|
$
|
54
|
|
$
|
4
|
|
$
|
76
|
|
$
|
133
|
|
|
Loan receivables
|
|
169
|
|
18
|
|
89
|
|
276
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
$
|
223
|
|
$
|
22
|
|
$
|
165
|
|
$
|
410
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Write-offs
|
|
$
|
(51
|
)
|
$
|
(1
|
)
|
$
|
(85
|
)
|
$
|
(137
|
)
|
|
Recoveries
|
|
1
|
|
1
|
|
0
|
|
2
|
|
|
Provision
|
|
(8
|
)
|
29
|
|
(4
|
)
|
16
|
|
|
Other
|
|
7
|
|
11
|
|
6
|
|
24
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Ending balance at December 31, 2017
|
|
$
|
172
|
|
$
|
61
|
|
$
|
82
|
|
$
|
314
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Lease receivables
|
|
$
|
63
|
|
$
|
9
|
|
$
|
31
|
|
$
|
103
|
|
|
Loan receivables
|
|
$
|
108
|
|
$
|
52
|
|
$
|
51
|
|
$
|
211
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Related allowance, collectively evaluated for impairment
|
|
$
|
43
|
|
$
|
15
|
|
$
|
6
|
|
$
|
64
|
|
|
Related allowance, individually evaluated for impairment
|
|
$
|
128
|
|
$
|
46
|
|
$
|
76
|
|
$
|
250
|
|
|
| Schedule of past due financing receivables |
|
|
|
|
|
|
|
Recorded
|
|
Billed
|
|
Recorded
|
|
|
|
|
Total
|
|
Recorded
|
|
Investment
|
|
Invoices
|
|
Investment
|
|
|
(Dollars in millions)
|
|
Recorded
|
|
Investment
|
|
> 90 Days and
|
|
> 90 Days and
|
|
Not
|
|
|
At March 31, 2018:
|
|
Investment
|
|
> 90 Days (1)
|
|
Accruing (1)
|
|
Accruing
|
|
Accruing (2)
|
|
|
Americas
|
|
$
|
3,898
|
|
$
|
278
|
|
$
|
242
|
|
$
|
27
|
|
$
|
38
|
|
|
EMEA
|
|
1,337
|
|
26
|
|
9
|
|
1
|
|
17
|
|
|
Asia Pacific
|
|
1,359
|
|
48
|
|
19
|
|
3
|
|
29
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total lease receivables
|
|
$
|
6,594
|
|
$
|
353
|
|
$
|
269
|
|
$
|
32
|
|
$
|
85
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Americas
|
|
$
|
6,272
|
|
$
|
265
|
|
$
|
168
|
|
$
|
31
|
|
$
|
103
|
|
|
EMEA
|
|
3,493
|
|
103
|
|
23
|
|
3
|
|
80
|
|
|
Asia Pacific
|
|
2,353
|
|
60
|
|
9
|
|
4
|
|
54
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total loan receivables
|
|
$
|
12,118
|
|
$
|
427
|
|
$
|
200
|
|
$
|
38
|
|
$
|
237
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
$
|
18,711
|
|
$
|
780
|
|
$
|
470
|
|
$
|
70
|
|
$
|
322
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1)
| |
At a contract level, which includes total billed and unbilled amounts for financing receivables aged greater than 90 days. |
|
(2)
| |
Of the recorded investment not accruing, $265 million is individually evaluated for impairment with a related allowance of $251 million. |
|
|
|
|
|
|
|
Recorded
|
|
Billed
|
|
Recorded
|
|
|
|
|
Total
|
|
Recorded
|
|
Investment
|
|
Invoices
|
|
Investment
|
|
|
(Dollars in millions)
|
|
Recorded
|
|
Investment
|
|
> 90 Days and
|
|
> 90 Days and
|
|
Not
|
|
|
At December 31, 2017:
|
|
Investment
|
|
> 90 Days (1)
|
|
Accruing (1)
|
|
Accruing
|
|
Accruing (2)(3)
|
|
|
Americas
|
|
$
|
3,911
|
|
$
|
239
|
|
$
|
197
|
|
$
|
29
|
|
$
|
44
|
|
|
EMEA
|
|
1,349
|
|
32
|
|
5
|
|
3
|
|
27
|
|
|
Asia Pacific
|
|
1,333
|
|
57
|
|
23
|
|
3
|
|
36
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total lease receivables
|
|
$
|
6,593
|
|
$
|
328
|
|
$
|
225
|
|
$
|
36
|
|
$
|
107
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Americas
|
|
$
|
6,715
|
|
$
|
345
|
|
$
|
254
|
|
$
|
38
|
|
$
|
96
|
|
|
EMEA
|
|
3,597
|
|
90
|
|
17
|
|
0
|
|
74
|
|
|
Asia Pacific
|
|
2,354
|
|
63
|
|
12
|
|
3
|
|
54
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total loan receivables
|
|
$
|
12,667
|
|
$
|
498
|
|
$
|
283
|
|
$
|
41
|
|
$
|
224
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
$
|
19,259
|
|
$
|
825
|
|
$
|
507
|
|
$
|
77
|
|
$
|
331
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1)
| |
At a contract level, which includes total billed and unbilled amounts for financing receivables aged greater than 90 days. |
|
(2)
| |
Of the recorded investment not accruing, $269 million is individually evaluated for impairment with a related allowance of $250 million. |
|
(3)
| |
Recast to conform to current period presentation, which includes billed impaired amounts. |
|
| Schedule of net recorded investment by credit quality indicator |
|
(Dollars in millions)
|
|
Lease Receivables
|
|
Loan Receivables
|
|
|
At March 31, 2018:
|
|
Americas
|
|
EMEA
|
|
Asia Pacific
|
|
Americas
|
|
EMEA
|
|
Asia Pacific
|
|
|
Credit Ratings:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Aaa — Aa3
|
|
$
|
391
|
|
$
|
53
|
|
$
|
56
|
|
$
|
629
|
|
$
|
137
|
|
$
|
98
|
|
|
A1 — A3
|
|
824
|
|
161
|
|
567
|
|
1,327
|
|
417
|
|
984
|
|
|
Baa1 — Baa3
|
|
983
|
|
373
|
|
341
|
|
1,583
|
|
968
|
|
592
|
|
|
Ba1 — Ba2
|
|
687
|
|
441
|
|
188
|
|
1,107
|
|
1,143
|
|
327
|
|
|
Ba3 — B1
|
|
522
|
|
196
|
|
95
|
|
840
|
|
508
|
|
164
|
|
|
B2 — B3
|
|
373
|
|
94
|
|
64
|
|
600
|
|
243
|
|
112
|
|
|
Caa — D
|
|
47
|
|
11
|
|
14
|
|
76
|
|
29
|
|
25
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
$
|
3,827
|
|
$
|
1,329
|
|
$
|
1,326
|
|
$
|
6,163
|
|
$
|
3,444
|
|
$
|
2,301
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(Dollars in millions)
|
|
Lease Receivables
|
|
Loan Receivables
|
|
|
At December 31, 2017:
|
|
Americas
|
|
EMEA
|
|
Asia Pacific
|
|
Americas
|
|
EMEA
|
|
Asia Pacific
|
|
|
Credit Ratings:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Aaa — Aa3
|
|
$
|
422
|
|
$
|
49
|
|
$
|
68
|
|
$
|
724
|
|
$
|
129
|
|
$
|
120
|
|
|
A1 — A3
|
|
855
|
|
190
|
|
544
|
|
1,469
|
|
502
|
|
961
|
|
|
Baa1 — Baa3
|
|
980
|
|
371
|
|
337
|
|
1,683
|
|
982
|
|
596
|
|
|
Ba1 — Ba2
|
|
730
|
|
448
|
|
184
|
|
1,253
|
|
1,186
|
|
325
|
|
|
Ba3 — B1
|
|
443
|
|
192
|
|
89
|
|
760
|
|
508
|
|
157
|
|
|
B2 — B3
|
|
367
|
|
77
|
|
64
|
|
630
|
|
204
|
|
113
|
|
|
Caa — D
|
|
51
|
|
13
|
|
18
|
|
88
|
|
34
|
|
31
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
$
|
3,847
|
|
$
|
1,340
|
|
$
|
1,302
|
|
$
|
6,607
|
|
$
|
3,545
|
|
$
|
2,303
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|